Hydroxychloroquine Sulfate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01611 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Quinquaud’s folliculitis decalvans | KG + DL |
| 2 | telogen effluvium | KG + DL |
| 3 | alopecia antibody deficiency | KG + DL |
| 4 | alopecia mucinosa | KG + DL |
| 5 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 6 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 7 | alopecia areata | KG + DL |
| 8 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 9 | juvenile chronic polyarthritis | KG + DL |
| 10 | rheumatoid nodulosis | KG + DL |
| 11 | juvenile idiopathic arthritis | KG + DL |
| 12 | echinococcus granulosus infectious disease | KG + DL |
| 13 | atrichia with papular lesions | KG + DL |
| 14 | acquired thrombocytopenia | KG + DL |
| 15 | alveolar echinococcosis | KG + DL |
| 16 | autosomal recessive familial Mediterranean fever | KG + DL |
| 17 | pseudoachondroplasia | KG + DL |
| 18 | osteoarthritis | KG + DL |
| 19 | Smouldering systemic mastocytosis | KG + DL |
| 20 | enterobiasis | KG + DL |
| 21 | familial Mediterranean fever, autosomal dominant | KG + DL |
| 22 | lichen disease | KG + DL |
| 23 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 24 | WHIM syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.